Palliative care at the end-of-life in glioma patients.

Handb Clin Neurol

Department of Neurology, Leiden University Medical Center, The Netherlands; Department of Neurology, Medical Center Haaglanden, The Hague, The Netherlands.

Published: December 2016

The end-of-life (EOL) phase of patients with a glioma starts when symptom prevalence increases and antitumor treatment is no longer effective. During the EOL phase, care is primarily aimed at reducing symptom burden while maintaining quality of life as long as possible without inappropriate prolongation of life. Palliative care during the EOL phase also involves complex medical decisions for the prevention and relief of suffering. We discuss the prevalence and treatment of the most common EOL symptoms, decision making in the EOL phase, the organization of EOL care, and the role of the patient's caregiver. Treating disease-specific symptoms, such as impaired consciousness, seizures, focal neurologic deficits and cognitive disturbances, is a major concern during the EOL phase, as these symptoms may interfere with EOL decision making. Advance care planning is aimed at reaching consensus about possible EOL decisions between all participants, respecting the values of patients and their informal caregivers. In order to prevent the possibility that the patient becomes incompetent to make informed decisions, we recommend initiating EOL conversations at a relatively early stage in the disease course.

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-12-802997-8.00019-0DOI Listing

Publication Analysis

Top Keywords

eol phase
20
eol
10
palliative care
8
decision making
8
phase
5
care end-of-life
4
end-of-life glioma
4
glioma patients
4
patients end-of-life
4
end-of-life eol
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!